These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21954046)

  • 1. MR spectroscopy of the human prostate using surface coil at 3 T: metabolite ratios, age-dependent effects, and diagnostic possibilities.
    Weis J; Jorulf H; Bergman A; Ortiz-Nieto F; Häggman M; Ahlström H
    J Magn Reson Imaging; 2011 Dec; 34(6):1277-84. PubMed ID: 21954046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
    Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
    Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility.
    Scheenen TW; Heijmink SW; Roell SA; Hulsbergen-Van de Kaa CA; Knipscheer BC; Witjes JA; Barentsz JO; Heerschap A
    Radiology; 2007 Nov; 245(2):507-16. PubMed ID: 17848681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
    Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
    Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
    Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
    Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
    Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW
    J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: external surface coil vs. endorectal surface coil.
    Kaji Y; Wada A; Imaoka I; Matsuo M; Terachi T; Kobashi Y; Sugimura K; Fujii M; Maruyama K; Takizawa O
    J Magn Reson Imaging; 2002 Dec; 16(6):697-706. PubMed ID: 12451583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer.
    Nagarajan R; Margolis D; McClure T; Raman S; Thomas MA
    Med Princ Pract; 2011; 20(5):444-8. PubMed ID: 21757934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study.
    Kaji Y; Kuroda K; Maeda T; Kitamura Y; Fujiwara T; Matsuoka Y; Tamura M; Takei N; Matsuda T; Sugimura K
    J Magn Reson Imaging; 2007 Mar; 25(3):517-26. PubMed ID: 17279524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
    Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
    Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F; Hricak H; Shinohara K; Kurhanewicz J; Vigneron DB; Nelson SJ; Carroll PR
    Urology; 1996 Oct; 48(4):594-9. PubMed ID: 8886066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of the prostate at 3.0T with external phased array coil - preliminary results.
    Morakkabati-Spitz N; Bastian PJ; Gieseke J; Träber F; Kuhl CK; Wattjes MP; Müller SC; Schild HH
    Eur J Med Res; 2008 Jun; 13(6):287-91. PubMed ID: 18558555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.
    Lagemaat MW; Vos EK; Maas MC; Bitz AK; Orzada S; van Uden MJ; Kobus T; Heerschap A; Scheenen TW
    Invest Radiol; 2014 May; 49(5):363-72. PubMed ID: 24335715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
    Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
    NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
    Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short echo time in vivo prostate ¹H-MRSI.
    Venugopal N; McCurdy B; Al Mehairi S; Alamri A; Sandhu GS; Sivalingam S; Drachenberg D; Ryner L
    Magn Reson Imaging; 2012 Feb; 30(2):195-204. PubMed ID: 22154684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer.
    Chung HT; Noworolski SM; Kurhanewicz J; Weinberg V; Roach Iii M
    BJU Int; 2011 Oct; 108(8 Pt 2):E164-70. PubMed ID: 21435153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.